期刊
CLINICAL OPHTHALMOLOGY
卷 5, 期 -, 页码 811-816出版社
DOVE MEDICAL PRESS LTD
DOI: 10.2147/OPTH.S6541
关键词
corticosteroids; anti-inflammatory; dose uniformity; relative potency
Purpose: To review the most recent published data regarding the novel potent steroid, difluprednate ophthalmic emulsion, 0.05%. Methods: A comprehensive search of recent published literature including difluprednate was performed. Clinical studies relevant to the characteristics and clinical efficacy of difluprednate in controlling postoperative inflammation were included, and a synopsis of each study was developed. Results: Several recent publications were identified in which difluprednate was shown to be efficacious in the treatment of postoperative inflammation in different clinical settings, including a novel perioperative regimen. Additional literature retrieved from this search included data on the relative potency of difluprednate, potential utility in the posterior segment, as well as the advantages of the emulsion formulation. Conclusion: Difluprednate has been studied extensively and shown in recent literature to be a safe and effective topical anti-inflammatory drug. The proven strength and unique formulation of difluprednate, along with its potent efficacy in treating and preventing inflammation, provides clinicians with a beneficial treatment option.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据